Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial

Kidney International

Volumn 59, Issue 4, 2001, Pages 1484-1490

  Cattran, Daniel C ^{a,b,c,d,e,f,g}   Appel, Gerald B ^{a,b,c,d,e,f,g}   Hebert, Lee A ^{a,b,c,d,e,f,g}   Hunsicker, Lawrence G ^{a,b,c,d,e,f,g}   Pohl, Marc A ^{a,b,c,d,e,f,g}   Hoy, Wendy E ^{a,b,c,d,e,f,g}   Maxwell, Douglas R ^{a,b,c,d,e,f,g}   Kunis, Cheryl L ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF TORONTO   (Canada)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f LOVELACE CLINIC FOUNDATION   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult onset nephrotic syndrome; Clinical trial; End stage renal failure; Immunosuppression; Progressive renal disease; Proteinuria

Indexed keywords

CREATININE; CYCLOSPORIN; PLACEBO; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MULTICENTER STUDY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0035067189     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590041484.x     Document Type: Article

References (39)

1. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997
2. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe and Australia/New Zealand: Results from and international comparative study
3. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy
4. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
5. Predicting progression in membranous glomerulonephritis
6. A review of therapeutic studies of idiopathic membranous glomerulopathy
7. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy
8. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults: The MRC Glomerulonephritis Working Party
9. Methylprednisolone in patients with membranous nephropathy and declining renal function
10. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function
11. Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure
12. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function
13. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone
14. Long-term cyclosporine a therapy for severe idiopathic membranous nephropathy
15. Treatment of membranous glomerulopathy with cyclosporine A: How much patience is required?
16. A controlled trial of cyclosporine in patients with progressive membranous nephropathy
17. Idiopathic nephrotic syndrome in adults: A study and classification based on renal biopsies
18. Natural history, clinical course and morphological evolution of membranous nephropathy
19. Idiopathic membranous nephropathy: The natural history of untreated patients
20. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults
21. Prognosis of untreated patients with idiopathic membranous nephropathy
22. Membranous nephropathy: Predictors of terminal renal failure
23. Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome
24. Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria
25. A controlled study of short-term prednisone treatment in adults with membranous nephropathy
26. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis
27. Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications
28. Blood pressure control, proteinuria, and the progression of renal disease
29. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies
30. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisone and chlorambucil with cyclosporine
31. Short-term responsiveness of membranous glomerulonephropathy to cyclosporine
32. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis
33. Cyclosporine in glomerulonephritis: A pilot study
34. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
35. Additive antiproteinuric effect of ACE inhibition and low-protein diet in human renal disease
36. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics
37. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: A prospective study of long-term treatment